A. SANRI Et Al. , "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia," 2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu , İzmir, Turkey, 2017
SANRI, A. Et Al. 2017. Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia. 2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu , (İzmir, Turkey).
SANRI, A., ÖZYILMAZ, B., MUTLU ALBAYRAK, H., ALTUNDAĞ, E., KARADAĞ ALPASLAN, M., CAN YILMAZ, G., ... KARA, C.(2017). Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia . 2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu, İzmir, Turkey
SANRI, ASLIHAN Et Al. "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia," 2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu, İzmir, Turkey, 2017
SANRI, ASLIHAN Et Al. "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia." 2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu , İzmir, Turkey, 2017
SANRI, A. Et Al. (2017) . "Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia." 2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu , İzmir, Turkey.
@conferencepaper{conferencepaper, author={ASLIHAN SANRI Et Al. }, title={Impact of CYP21A2 Gene Mutations on Clinical Management of Congenital Adrenal Hyperplasia}, congress name={2. Ege Endokrin Hastalıklar ve Genetik Sempozyumu}, city={İzmir}, country={Turkey}, year={2017}}